Capsule inhalers may be a little on the old-fashioned side, but the Breezhaler requires a relatively low inspiratory flow rate compared to some DPIs, which may make it easier for some patients to inhale the powder out of the device. Atectura comes in the Breezhaler, which is a capsule Dry Powder Inhaler (DPI), which involves inserting the capsule in the device, squeezing a button to pierce the capsule, and then inhaling quickly and deeply 2. In this respect, you can think of it a little like Relvar, which is also a once-a-day fixed-dose combination. It also lasts 24 hours so is only taken once a day, which might be an advantage to help with adherence for some. However, it is available in three different strengths, which provides some flexibility in dosing, often an advantage in a variable condition such as asthma. Atectura is a fixed-dose combination, meaning that you can’t increase and decrease the dose, as you can with formoterol-based combinations such as Symbicort and Fostair. It contains the ICS mometasone, and the LABA indacaterol, which are perhaps less well known than others but still effective medicines.

The good thing is that there are no extra devices for you to learn, just some extra combinations to provide another option for your people with Chronic Obstructive Pulmonary Disease (COPD) and asthma.Ītectura Breezhaler is a new inhaled corticosteroid (ICS) and long-acting B2 agonist (LABA) for asthma, marketed by Novartis. This time last year we were running out of inhalers, 1 and now we seem to be overrun by them. If you’re the kind of person who breaks out in a cold sweat every time you hear someone say “have you seen the latest inhaler that’s just come out,” then you may wish to pause a moment, light some scented candles, turn on some soothing music, and take a deep breath.

Lama laba vs symbicort